Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Cardiovascular outcomes from the clinical trials were encouraging, potentially reducing the burden on cardiology departments worldwide
Lilly and Nimbus have been partnering for more than three years on developing a small molecule activator of a specific isoform of AMP-activated protein kinase (AMPK) to treat cardiometabolic diseases, under an up-to-$496 million partnership launched in 2022
A compound that supports all injured structures together could meaningfully compress recovery timelines
Estimates published before approval should be treated as speculation
Semaglutide : This drug is used for individuals with obesity and rare inherited disorders
US$ 21.42
US$ 22.17
US$ 21.74
US$ 29.91
US$ 20.96
US$ 23.30
